Momentum Stocks: IAMGOLD Corp. (NYSE:IAG), Seadrill Partners LLC (NYSE:SDLP), SORL Auto Parts (NASDAQ:SORL), Zynga Inc (NASDAQ:ZNGA), Arena Pharmaceuticals (NASDAQ:ARNA)

On last trading day IAMGOLD Corp. (NYSE:IAG) advanced 1.79% to close at $2.28. Its volatility for the week is 4.65% while volatility for the month is 4.61%. IAG’s sales growth for past 5 years was 2.00% and its EPS growth for past 5 years was -42.10%. IAMGOLD Corp. (NYSE:IAG) monthly performance is 15.15%. On 26 April, IAMGOLD Corporation (NYSE:IAG) reported with deep regrets that a member of the Company’s Exploration team in Mali has passed away from injuries sustained in an accident, after the vehicle in which he was travelling, according to preliminary reports, hit a tree after leaving the road.

On last trading day Seadrill Partners LLC (NYSE:SDLP) moved down -0.26% to close at $15.62. Its volatility for the week is 5.43% while volatility for the month is 3.97%. SDLP’s EPS growth for past 5 years was 183.26%. Seadrill Partners LLC (NYSE:SDLP) monthly performance is 23.87%. Seadrill Partners LLC (NYSE:SDLP) partners board of directors has declared a quarterly cash distribution with respect to quarter ended March 31, 2015 of $0.5675 per unit, in line with the Q4 distribution. This cash distribution will be paid on or about May 14, 2015 to all unitholders of record as of the close of business on May 7, 2015.

On last trading day SORL Auto Parts, Inc. (NASDAQ:SORL) moved down -4.83% to close at $3.35. Its volatility for the week is 5.84% while volatility for the month is 5.89%. SORL’s sales growth for past 5 years was 11.00% and its EPS growth for past 5 years was -1.60%. SORL Auto Parts, Inc. (NASDAQ:SORL) monthly performance is -7.97%. TheStreet upgraded shares of Sorl Auto Parts Inc. (NASDAQ:SORL) from a hold rating to a buy rating in a report issued on 27 April.

On Monday shares of Zynga Inc (NASDAQ:ZNGA) closed at $2.49. Company’s sales growth for last 5 years was 41.50% and EPS growth for next 5 years is recorded as 30.00%. On 27 April, Zynga Inc. (NASDAQ:ZNGA) has entered into retention agreements with two of its executives, after the gaming company’s chief executive and operating chief resigned in recent weeks.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in last trading activity decreased -0.69% to close at $4.31. Company weekly performance is 2.13% while its quarterly performance stands at -1.37%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is -40.30% away from its 52 week high. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on April 29, 2015, released favorable results from a Phase 1 single-ascending dose clinical trial of APD371, a highly selective and potent agonist of the cannabinoid 2 (CB2) receptor currently in development for the treatment of pain and potentially fibrotic diseases. The randomized, double-blind and placebo-controlled Phase 1 clinical trial enrolled 56 healthy adults to evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of APD371.

Leave a Reply

Your email address will not be published. Required fields are marked *

*